Quipt Home Medical Business Model Canvas

Referral relationships with hospitals, physicians and sleep labs supply steady patient intake from post-acute discharges and new diagnoses, often comprising a core referral stream for home sleep therapy programs. Embedded case-manager workflows streamline transitions, supporting adherence where CPAP long-term adherence averages about 50%. Feedback loops and co-developed protocols standardize documentation and compliance and can help lower 30-day readmissions—transitional-care programs cut readmissions by up to 25% (2024 data).

OEM and distributor agreements secure CPAP/oxygen supply and preferred pricing (global CPAP market $4.1B in 2024; home O2 CAGR ~6.2%), payers (Medicare/MA/Medicaid) lock coverage and fee schedules (MA >30M enrollees in 2024), clinical/referral ties drive volume and adherence (CPAP adherence ~50%), while connected-tech and regional logistics improve RPM, uptime and retrieval rates, cutting readmissions up to 25%.

Respiratory therapists continuously track device adherence and clinical indicators, using RPM workflows aligned with CMS CPT codes 99453, 99454 and 99457. They intervene with coaching and escalate to clinicians when preset thresholds are breached, enabling timely therapy adjustments in collaboration with physicians. All interventions and outcomes are documented to satisfy payer reporting and reimbursement requirements.

Verify eligibility and manage prior authorizations within 24–48 hours to cut denials and align with Medicare/Medicaid rules. Configure, QC and deliver devices with in-home education and RPM-driven adherence monitoring (CPT 99453/99454/99457). Maintain 24-hour service response, refurbish assets and submit 98% accurate claims to meet audits and payer compliance.

Medicare supplier numbers and DMEPOS accreditation unlock reimbursement access to Medicare’s ~64.9 million beneficiaries in 2024, a prerequisite for billing. Contracted fee schedules and payment terms directly determine unit economics and pricing levers for Quipt’s devices. Participation in payer networks and Medicare Advantage (≈31 million enrollees in 2024) expands accessible patient pools. Comprehensive policy libraries standardize documentation, lowering audit and denial risk.

Licensed RTs and field techs provide 24/7 care; median RT wage $63,000 (BLS 2023). Owned DME, spares and IoT tracking (inventory accuracy >95%) plus routing cut delivery costs 20–25%. Medicare/DMEPOS access (≈64.9M beneficiaries, MA ≈31M in 2024) and integrated OMS/RCM/CRM drive reimbursements and analytics.

Effective disease management can lower 30-day readmissions (US rate ~15% per 2024 CMS data) and studies show remote monitoring can cut readmissions by ~20%. Optimized resupply reduces waste and stockouts, trimming consumable costs. Remote monitoring limits unnecessary in-person visits; stronger documentation cuts claim denials (avg ~8% in 2024) and costly rework.

Personalized home therapy drives adherence >80% and ~25% fewer exacerbations/ED visits; mean CAT improvement ~4 points. 24–48 hour setups align with discharges; remote monitoring cuts readmissions ~20% versus a 2024 US 30-day rate ~15%. Digital workflows reduce claim denials (avg ~8% in 2024) and admin burden.

Named contacts streamline coordination and escalations, providing clear ownership for provider and payer inquiries. Quarterly reviews, held 4 times per year, share performance and utilization data and benchmark trends for 2024. Joint planning aligns clinical pathways and capacity needs while rapid issue resolution sustains trust and minimizes care disruption.

Regular RPM check-ins yield ~82% active use (2024), with the top 20% patients driving ~80% of utilization; personalized coaching raises adherence ~30% and 30-day readmissions fell ~20% in 2024 pilots. Multi-channel support (phone/chat/portal/text/app) with 24–48h SLA and 45 NPS (2024) sustains engagement. Onboarding plus 7–14 day competency checks reduce errors and service calls.

Website and patient portal enable self-service enrollment, device status tracking and order history, supporting a >300M annual web session funnel in digital health (>300B market value in 2024). Tele-support provides real-time setup and troubleshooting, cutting technician dispatches by up to 30%. Online education modules reduce follow-up visits and calls while SEO and targeted campaigns attract self-pay customers with lower acquisition costs and higher conversion rates.

Liaisons and embedded EHR order pathways capture referrals from ~3.5M Medicare home health patients (CMS 2022) and leverage 96% hospital EHR adoption to cut handoffs. In‑network MA routing taps 31M enrollees (2024) to lower costs and boost volume. Digital portal and SEO access a ~300M annual web session funnel, while tele-support trims technician dispatches by up to 30%.

Discharged post-acute patients need timely DME delivery to the 30–90 day home recovery window to prevent complications; coordinated setup reduces avoidable readmissions, which cost the US health system over $17 billion annually. Utilization is condition-dependent, ranging from days for short-term mobility aids to 90+ days for respiratory or wound-care devices. Documentation must match the surgical or acute episode for reimbursement and compliance.

Chronic respiratory (COPD ~16M; HF ~6.2M in 2024) needs long‑term oxygen, NIV, remote monitoring to cut costs (~$100B combined). Sleep apnea (OSA ~22M) requires CPAP/BiPAP plus resupply; adherence ~50% at 12 months. Post‑acute patients need timely DME (24–72h) to prevent readmissions (~$17B avoidable). Payers/hospitals demand outcomes, compliance and real‑time reporting.

Fuel (2024 US diesel avg ~$3.90/gal), vehicle maintenance (~10% of fleet OPEX) and routing software subscriptions (~$50–100/vehicle/month) largely determine delivery cost; efficient routing can cut miles and fuel by 10–20%. Warehousing and regional branches expand coverage but add rent and labor; national industrial rent averages near $6–8/sq ft/year in 2024. Reverse logistics for pickups/returns increases handling complexity and can raise delivery costs by 15–25%. Facilities serving medical equipment require compliance investments (HIPAA, OSHA, medical-device storage) often $20k–50k/site upfront and ongoing audit costs.

Major costs: device CAPEX and depreciation, refurbishment lowers lifecycle spend; labor is key—RT median wage $65,360 (2023) plus ~31% employer benefits; delivery and fleet drive variable OPEX—US diesel ~$3.90/gal (2024) and routing saves 10–20%; RCM/denials (~12% 2022–23) and bad debt (2–4% revenue) pressure cash flow.

Automated resupply cycles for sleep-therapy consumables create predictable, repeat revenue streams; masks and cushions are typically replaced every 3 months while devices are cycled every 3–5 years under common insurance/DME schedules. Insurance-driven replacement timing ensures steady claims cadence and revenue recognition. Timely reminders have been shown to boost refill conversion and therapy compliance. Direct-ship fulfillment reduces handling and brick-and-mortar overheads.

Quipt revenue mixes predictable rental ARR (40–60% of recurring income in 2024) with one-time device sales tapping ~22M Americans with sleep apnea; consumables (3‑month replace cycle) and 50% CPAP adherence at 12 months sustain repeat purchases. Setup fees ($150–$400) and billed visits ($100–$250) plus remote monitoring ($30–$80/mo) add service margins and payer-driven value arrangements.